The verdict on COVID-19 booster shots is in. The feds have determined and authorized that some individuals should receive booster shots to bolster the effects of their original vaccinations. Update: On Sept. 22, “the U.S. Food and Drug Administration (FDA) amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to allow for use of a single booster dose, to be administered at least six months after completion of the primary series,” an FDA release said. The following individuals — who completed their first vaccination series at least six months ago — are recommended to receive the booster shot, according to Centers for Disease Control and Prevention (CDC) guidance: Soon after the FDA and CDC updates, the Centers for Medicare & Medicaid Services (CMS) reminded that it would fully cover COVID-19 vaccinations for Medicare beneficiaries, including the booster shots. “T Biden-Harris Administration has made the safe and effective COVID-19 vaccines accessible and free to people across the country. CMS is ensuring that cost is not a barrier to access, including for boosters,” said CMS Administrator Chiquita Brooks-LaSure in a Sept. 24 release. “CMS will pay Medicare vaccine providers who administer approved COVID-19 boosters, enabling people to access these vaccines at no cost.” The Medicare payment rates for a single dose of the “COVID-19 vaccines administered on or after March 15, 2021, additional doses of the COVID-19 vaccine administered to immunocompromised individuals on or after August 12, 2021, and booster doses administered to certain populations on or after September 22, 2021” are about $40 for single-dose vaccines and $40 for additional doses and boosters, CMS indicates in its COVID-19 vaccination payment guidance. Read the FDA authorization at . Review CDC guidance at . Find the CMS release and additional Medicare provider links on vaccination administration at .